Executive Summary
Across the four filings in the India Corporate Insolvency & NCLT stream, dominant themes include ongoing Corporate Insolvency Resolution Processes (CIRP) for Radhagobind Commercial Limited (two filings) and Shirpur Gold Refinery Ltd, characterized by bearish sentiment, critical risk levels, and complete absence of financial metrics, period-over-period comparisons, or resolution progress. No YoY/QoQ trends, revenue growth, margin data, or operational metrics were disclosed due to insolvency constraints, highlighting severe transparency gaps for Q4 FY2026 (ended Dec 31, 2025). Apollo Hospitals Enterprise Limited stands out as a neutral outlier with a low-materiality analyst meet, devoid of adverse updates. Portfolio-level patterns reveal 3/4 filings at critical insolvency stages (early public announcement to mid-late 4th CoC meeting), signaling heightened liquidation risks and non-compliance with SEBI LODR Reg 33. Market implications include potential stock suspensions, delistings, and distress opportunities in commercial and gold refinery sectors, with no forward-looking guidance, insider activity, capital allocation, or scheduled events to provide positive catalysts.
Tracking the trend? Catch up on the prior India NCLT Insolvency Resolution Filings digest from February 13, 2026.
Investment Signals(10)
- Radhagobind Commercial (Filing 1)(BEARISH)▲
4th CoC meeting outcome on Feb 14, 2026 confirms mid-to-late CIRP stage with no resolution plans or creditor details disclosed
- Radhagobind Commercial (Filing 4)(BEARISH)▲
CIRP Public Announcement for period ended Dec 31, 2025 signals early-stage insolvency initiation due to undisclosed financial default
- Shirpur Gold Refinery(BEARISH)▲
Non-submission of Q4 2025 financial results (ended Dec 31, 2025) under SEBI LODR Reg 33 due to CIRP-related data unavailability
- Radhagobind Commercial↓(BEARISH)▲
Dual filings on same day (Feb 14, 2026) indicate accelerated CIRP progression from public announcement to 4th CoC without viability updates
- Shirpur Gold Refinery(BEARISH)▲
Ongoing CIRP with zero financial transparency contrasts with typical quarterly disclosures, amplifying distress signals
- Apollo Hospitals↓(NEUTRAL)▲
Analyst/Investor meet outcome under Reg 30 on Feb 14, 2026 with no negative disclosures or strategic concerns
- Radhagobind Commercial↓(BEARISH)▲
Absence of any YoY/QoQ financial trends, ratios (e.g., Debt-to-Equity), or operational metrics in CIRP filings underscores deteriorating health
- Shirpur Gold Refinery(BEARISH)▲
CIRP update tied to Q4 2025 non-disclosure highlights regulatory non-compliance vs peers submitting results
- Cross-Company(BEARISH)▲
3/4 filings lack insider trading activity, forward-looking statements, or capital allocation details amid insolvency
- Apollo Hospitals↓(NEUTRAL TO BULLISH)▲
Only filing with neutral sentiment (1/10 materiality) vs critical bearish peers, potential relative outperformance
Risk Flags(9)
- Radhagobind Commercial/Filing 1↓[HIGH RISK]▼
Ongoing mid-to-late CIRP (4th CoC on Feb 14, 2026) with no resolution plans risks progression to liquidation
- Radhagobind Commercial/Filing 4↓[CRITICAL RISK]▼
CIRP Public Announcement for Dec 31, 2025 period signals default admission, no creditor/claim details
- Shirpur Gold Refinery/Regulatory[HIGH RISK]▼
SEBI LODR Reg 33 non-compliance for Q4 2025 results due to financial data unavailability
- Radhagobind Commercial/CIRP Stage↓[CRITICAL RISK]▼
Rapid updates from early announcement to 4th CoC on same day (Feb 14, 2026) without positive developments
- Shirpur Gold Refinery/Transparency[HIGH RISK]▼
Zero disclosure on operational metrics, capacity, volumes, or costs amid ongoing CIRP
- Cross-Insolvency/Financials[CRITICAL RISK]▼
No period-over-period comparisons (YoY/QoQ), ratios (ROE, margins), or trends available in 3/4 filings
- Radhagobind Commercial/Liquidation↓[HIGH RISK]▼
Lack of viable plan details post-4th CoC increases NCLT liquidation probability
- Shirpur Gold Refinery/Sector[HIGH RISK]▼
Gold refinery distress with no business viability updates, potential sector contagion
- Portfolio-Level/No Catalysts[HIGH RISK]▼
Absence of forward-looking guidance, insider activity, or scheduled events in insolvency filings
Opportunities(8)
- Radhagobind Commercial/Resolution Play↓(OPPORTUNITY)◆
Monitor for resolution plan approvals post-4th CoC (Feb 14, 2026); successful bids could yield 2-5x recovery for distressed debt investors
- Shirpur Gold Refinery/Distressed Short(OPPORTUNITY)◆
Critical CIRP with Reg 33 non-compliance and no Q4 2025 data offers short opportunity ahead of potential delisting
- Radhagobind Commercial/Early CIRP↓(OPPORTUNITY)◆
Public Announcement stage (Dec 31, 2025 reference) allows positioning for undervalued asset sales if liquidation avoided
- Apollo Hospitals/Relative Strength↓(OPPORTUNITY)◆
Neutral analyst meet (Feb 14, 2026) vs bearish peers positions it as safe haven in healthcare amid insolvency wave
- Cross-Company/Distressed Assets(OPPORTUNITY)◆
3 insolvency filings highlight potential M&A carve-outs (no transaction details yet) at deep discounts
- Shirpur Gold Refinery/Gold Sector(OPPORTUNITY)◆
CIRP distress vs rising gold prices creates turnaround alpha if resolution plan revives operations
- Radhagobind Commercial/CoC Momentum↓(OPPORTUNITY)◆
4th CoC outcome could trigger plan shortlisting; watch for bidder inflows
- Portfolio Hedging(OPPORTUNITY)◆
Use bearish insolvency signals to overweight stable names like Apollo Hospitals (low 1/10 materiality)
Sector Themes(6)
- Persistent CIRP Delays(BEARISH IMPLICATIONS)◆
3/4 filings show ongoing insolvency (early to mid-late stages) with no resolutions, implying 180-270 day IBC timelines at risk of extension
- Financial Blackout(HEIGHTENED DISTRESS)◆
Complete absence of YoY/QoQ trends, ratios, margins in all CIRP cos (Radhagobind x2, Shirpur) vs standard disclosures
- Regulatory Non-Compliance[RISK TO LISTINGS]◆
Shirpur's Reg 33 failure for Q4 2025 (Dec 31) exemplifies SEBI-IBC friction, 1/4 filings impacted
- Neutral Outlier in Healthcare(RELATIVE BULLISH)◆
Apollo's low-risk analyst meet (Feb 14, 2026) contrasts critical bearish peers, signaling sector resilience
- Commercial & Refinery Distress(SECTOR ROTATION AWAY)◆
Undisclosed sectors for Radhagobind + gold for Shirpur show small-cap vulnerabilities, no capex/reinvestment signals
- No Capital Returns(BEARISH FOR EQUITY)◆
Zero dividends, buybacks, or splits in filings; full focus on creditor recovery over shareholders
Watch List(8)
Track 5th CoC meeting post-Feb 14, 2026 outcome for resolution plan approvals or liquidation vote
Monitor NCLT orders following public announcement (Dec 31, 2025 reference) for admission/progress
- Shirpur Gold Refinery/Financial Submission👁
Watch for delayed Q4 2025 results or CIRP update explaining data unavailability
- Shirpur Gold Refinery/Reg 33 Compliance👁
Upcoming SEBI penalties or extensions due to non-submission for quarter ended Dec 31, 2025
Any pledges/holdings disclosures amid CIRP; absence noted in current filings
Follow-up from Feb 14, 2026 analyst meet for any indirect sector insights on insolvencies
- Cross-Portfolio/Liquidation Risks👁
All 3 CIRP cos for NCLT liquidation orders within 270 days from initiation
- Shirpur Gold Refinery/Resolution Bids👁
Potential plan submissions post-current update; gold price rally as catalyst
Filing Analyses(4)
14-02-2026
Radhagobind Commercial Limited (539673) disclosed the outcome of the 4th Committee of Creditors (CoC) meeting held on February 14, 2026, as part of the ongoing Corporate Insolvency Resolution Process (CIRP). No specific details regarding the meeting outcome, creditor claims, resolution plans, or financial metrics were provided in the filing summary. This update confirms continued insolvency proceedings without resolution or liquidation indicated.
- ·Event: Outcome of 4th CoC meeting
- ·CIRP stage: Ongoing (4th CoC meeting indicates mid-to-late CIRP phase)
- ·Sector: NOT_DISCLOSED
14-02-2026
Apollo Hospitals Enterprise Limited (BSE: 508869) announced the outcome of an Analyst / Investor Meet under SEBI LODR Regulation 30, held on February 14, 2026. No specific details regarding discussions, financial metrics, leadership changes, board outcomes, or strategic decisions were disclosed in the filing. Sector information was not specified.
14-02-2026
Shirpur Gold Refinery Ltd provided an update on its ongoing Corporate Insolvency Resolution Process (CIRP), stating that financial results for the quarter ended December 31, 2025, were not submitted under Regulation 33 of SEBI (LODR) Regulations, 2015, due to non-availability of financial information. This highlights continued insolvency proceedings with no financial transparency or metrics disclosed. No positive operational or financial developments are mentioned.
- ·CIRP stage: Ongoing (updates provided)
- ·Quarter reference: Ended December 31, 2025
- ·Reason for non-submission: Non-availability of financial information
14-02-2026
Radhagobind Commercial Ltd (BSE: 539673) issued a Public Announcement for Corporate Insolvency Resolution Process (CIRP) on February 14, 2026, pertaining to the period ending December 31, 2025. No financial metrics, default amounts, creditor details, or resolution timelines are disclosed. This marks the early stage of insolvency proceedings under IBC, signaling severe financial distress with no operational or positive developments mentioned.
- ·Event Type: Insolvency - CIRP Public Announcement
- ·Period referenced: 31-12-2025
- ·Source: BSE
- ·Sector: NOT_DISCLOSED
Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 4 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 25, 2026
India Pre-Market Regulatory Roundup — March 25, 2026
India Pre-Market Regulatory Roundup